AL cardiac amyloidosis and arterial thromboembolic events

Author： Hausfater P.   Costedoat N.   Amoura Z.   Cacoub P.   Papo T.   Grateau G.   Leblond V.   Godeau P.   Piette J. C.  

Publisher： Informa Healthcare

ISSN： 0300-9742

Source： Scandinavian Journal of Rheumatology, Vol.34, Iss.4, 2005-08, pp. : 315-319

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiac amyloidosis: the heart of the matter

By Perfetto Federico  

Internal and Emergency Medicine, Vol. 8, Iss. 3, 2013-04 ,pp. : 191-203

Springer Publishing Company

Access to resources Recommend Favorite

Antiplatelet therapy in prevention of cardio- and venous thromboembolic events

By Steinhubl Steven   Eikelboom John   Hylek Elaine   Dauerman Harold   Smyth Susan   Becker Richard  

Journal of Thrombosis and Thrombolysis, Vol. 37, Iss. 3, 2014-04 ,pp. : 362-371

Springer Publishing Company

Access to resources Recommend Favorite

Thromboembolic Events in Patients Treated with Anti-Angiogenic Drugs

By  

Current Vascular Pharmacology, Vol. 8, Iss. 1, 2010-01 ,pp. : 102-113

Bentham Science Publishers

Access to resources Recommend Favorite

Uptake of technetium 99m HDP in cardiac amyloidosis

By Kulhanek J.  

The International Journal of Cardiac Imaging, Vol. 19, Iss. 3, 2003-06 ,pp. : 225-227

Springer Publishing Company

Access to resources Recommend Favorite

Noninvasive diagnosis of biopsy-proven cardiac amyloidosis

By Rahman J.E.   Helou E.F.   Gelzer-Bell R.   Thompson R.E.   Kuo C.   Rodriguez E.R.   Hare J.M.   Baughman K.L.   Kasper E.K.  

Journal of the American College of Cardiology, Vol. 43, Iss. 3, 2004-02 ,pp. : 410-415

Elsevier

Access to resources Recommend Favorite